Skip to content
info@rnmcenter.com
+91 83073 55621
+91 96712 06780
+91 96713 06780
Facebook
Linkedin
Instagram
Youtube
Menu
About Us
Services
PET-CT Services
Gamma Camera Scans
Radionuclide Therapy
Patient’s Corner
Nuclear Medicine Therapy
Information About PET-CT
Information About Radionuclide Therapy
Safety Profile
Patient Instructions
Referral Doctor’s Corner
Indications for radionuclide therapies
Indications for PET-CT
Indications for Gamma Camera
Contact Us
Radionuclide Therapy in Rohtak
I-131 radioiodine Therapy
Hyperthyroidism: Treatment for Graves' disease and toxic nodular goiter
Differentiated Thyroid Cancer: Ablation of residual thyroid tissue and treatment of metastatic disease- nodal, lungs, skeletal
Lutetium-Lu-177 DOTATATE(PRRT therapy)
metastatic neuroendocrine tumors grade 1, 2
Lutetium-Lu-177 PSMA therapy
metastatic castrate resistant prostate cancer- post ARPI, pre and post chemotherapy
Lutetium-Lu-177 FAPI therapy
Advanced cancers with FAPI PET positivity with exhausted options- sarcomas, breast, ovary, pancreas, lung.
Terbium-161 DOTA
therapy– neuroendocrine tumors
Terbium-161 PSMA
therapy– metastatic castrate resistant prostate cancer- post ARPI, pre and post chemotherapy.
Actinium 225 PSMA
therapy– metastatic castrate resistant prostate cancer- post ARPI, pre and post chemotherapy
Actinium 225-DOTA
therapy– neuroendocrine tumors
Lutetium-Lu-177 EDTMP therapy
pain palliation therapy for osteoblastic skeletal metastasis
Call Now Button
Automated page speed optimizations for fast site performance